NEWS THAT NATIONAL HEALTH SERVICE (NHS) PATIENTS IN ENGLAND ARE TO BENEFIT FROM A NEW £340 MILLION (US$473 MILLION; €398 MILLION) PER ANNUM INNOVATIVE MEDICINES FUND (IMF) – ORIGINALLY PROMISED BY THE CONSERVATIVE GOVERNMENT IN ITS 2019 RE-ELECTION MANIFESTO – HAS BEEN WARMLY GREETED BY STAKEHOLDERS ACROSS THE SPECTRUM. EXPECTATIONS ARE HIGH THAT THE FUND WILL DELIVER FAST-TRACK ACCESS TO THE MOST INNOVATIVE NEW TREATMENTS, INCLUDING FOR ORPHAN AND RARE DISEASES. BUT WITH DETAILS OF THE SCHEME STILL THIN ON THE GROUND, IT’S NOT YET CLEAR HOW AND WHEN PATIENTS WILL BEGIN TO BENEFIT FROM THE INITIATIVE.
NHS England on 21 July stated that the IMF is to be implemented alongside the existing cancer drugs fund (CDF) and will “support the NHS to fast-track patient access to treatments which can demonstrate substantial clinical promise but still have significant uncertainty around their clinical and cost effectiveness and hence long term value for taxpayers”. With the CDF also benefiting from an annual budget of £340 million, the establishment of the new Fund will, according to NHS England, mean that a total of £680 million in ring-fenced funding will be available annually to expedite access to new treatments.
从表面上看，IMF无疑对患者来说是个好消息。根据卫生和社会护理部长萨吉必威手机APP德·贾维德（Sajid Javid）的说法，新基金将扩展CDF模型以涵盖更多的治疗方法。实际上，这可能意味着国际货币基金组织将作为有条件的报销计划，使选定的药物在NHS中涵盖，同时在国立卫生研究所进行最终评估之前收集了进一步的证据。必威手机APP卓越（不错）。自2016年以来，CDF一直使用该模型，尽管最初反对行业，但已证明耐用性，并赢得了患者倡导者（例如UK Cancer Research UK）的支持。
Basing the IMF on the existing CDF model would also ensure that the new Fund avoids much of the controversy that the cancer fund faced upon its establishment back in 2011. Then, the open-ended nature of the CDF left it vulnerable to criticism that it might be used to circumvent the NICE evaluation process – a criticism that the 2016 overhaul of the CDF has since largely addressed. The launch of the IMF has the advantage, too, of addressing another key criticism levelled at the CDF, namely that the cancer fund “privileges” oncology over other therapy areas. By providing dedicated funding for the most promising treatments, regardless of the condition to be treated, the new IMF could enable many more patients to benefit from faster access to new medicines.
此外，国际货币基金组织可以帮助解决枯萎卫生系统的一些区域不平等现象。必威手机APP在苏格兰，自2014年以来，患者一直能够通过专用的新药物基金获得创新的超庞然大物，孤儿和临终治疗的资金，而在这方面，国际货币基金组织可能会为患有这种情况的患者带来类似的好处。英国。然而，与此同时，其他不平等将持续存在：威尔士或北爱尔兰居民仍然无法获得此类资金，并且单独的癌症基金将仅对英格兰的患者开放。
此外，尽管保证新的IMF将模仿现有的CDF，但NHS England尚未发布有关该基金如何在实践中运作的详细信息。目前尚不清楚NHS如何通过该计划选择用于资金的产品，也不清楚IMF如何与NIDE相互作用。根据该计划的入学标准，有些产品可能仍然不合格 - 并且在有限的资金库中，有些患者将不可避免地失望。
For now, the Association of the British Pharmaceutical Industry (ABPI) and others have welcomed the Fund as an “important step towards improving access to new medicines for NHS patients”. With a stakeholder consultation due later in 2021, manufacturers may not have long to wait to find out just how big a step forward the IMF really is.
IQVIA Pharma定价和报销（PPR）利用了数十年的市场访问空间经验，为您带来了定价和报销方面的最新全球发展。通过访问IQVIA的本地办事处网络以及政府和行业内部的广泛联系，PPR服务提供了及时的新闻和文章，以及全球P＆R法规的全面指南。提前有关IQVIA Pharma定价和报销的更多信息，请与我们联系这里.